4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-053884
CFO & Executive Vice President sold 1,629 shares at $40.16 ($65,421)
From the SEC's structured data for this filing
Trades in this filing
Dier Mardi · CFO & Executive Vice President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-14 | Sale : show line 1 in the form | −1,629 | $40.16 | $65,421 | 66,695 | D |
| Open-market sales · 1,629 sh · avg $40.16 · $65,421 | ||||||
Loading xslF345X03/doc4.xml…